Prevalence of 'dural tail sign' in patients with different intracranial pathologies

The purpose of this study is to clarify the prevalence, spectrum of associated tumors and the diagnostic value of the linear meningeal thickening and enhancement adjacent to a peripherally located cranial mass 'dural tail sign' (DTS) in contrast enhanced magnetic resonance imaging (MRI). In this prospective descriptive cross-sectional study conducted from 2002 to 2005, 110 patients with imaging-proven intracranial lesions and no history of previous intracranial surgery were referred to the neurosurgery clinic of our hospital for surgical resection. All underwent imaging with a 1.5 T MR system with and without contrast injection. Twelve patients were excluded from our study and finally 98 patients were evaluated for the presence of 'dural tail sign'. Twenty-two of 98 patients (22.44%) with intracranial masses exhibited the 'dural tail sign' (18 meningiomas, 2 pituitary adenomas, 1 primary cerebral lymphoma and 1 fungal brain abscess). Fifty-eight percent of the patients with biopsy-proven meningioma were observed to show 'dural tail sign'. In conclusion, we found the 'dural tail sign' to have a sensitivity of 58.6% and specificity of 94.02% in diagnosis of meningioma